Darovasertib

CAS No.

1874276-76-2

MDL No.

MFCD31544328

C₂₂H₂₃F₃N₈O

472.50

InChI Key

XXJXHXJWQSCNPX-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

Darovasertib is an orally available PKC inhibitor with immunosuppressive and antineoplastic properties. It inhibits PKC, preventing activation of PKC-mediated signaling pathways, which may induce cell cycle arrest and apoptosis in susceptible tumor cells.

CAS No.	1874276-76-2
Product Name	Darovasertib

Associated Conditions

Uveal Melanoma·melanoma

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Documentation

Darovasertib

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Related Articles

Rebound phenomena in manic patients following physostigmine. Preliminary observations.

Documentation